Comment on OMB-2026-0034-0001

This comment is submitted by The Optimum Department, LLC, an independent research infrastructure strategy consultancy, drawing on nearly twenty years of experience in research administration, grant finance, and compliance at research-intensive universities. It is submitted on behalf of the firm and the commenter individually, not on behalf of any institution, client, or employer. The full analysis is provided in the attached document. The comment opposes the proposed rule and urges OMB to withdraw it. It raises a threshold objection that OMB lacks statutory authority for the rulemaking, and provides provision-specific analysis of the most serious legal and implementation defects. Threshold authority: OMB grounds the rule in 31 U.S.C. § 503(a)(2), a financial-management coordination authority that OMB has administered as guidance for four decades. The proposal would convert that framework into binding regulation imposing substantive conditions directly on recipients, a power § 503(a)(2) does not confer. Unlike the Federal Acquisition Regulation, which Congress expressly authorized, no statute authorizes direct government-wide regulation of grant recipients. The proposed agency co-issuance is ceremonial; the adopting provisions reserve all substance and amendment authority to OMB. Procedural objection: the 45-day comment period is inadequate for a rule spanning nine CFR parts, co-issued by dozens of agencies, that converts the framework's legal character and introduces substantive conditions. It is shorter than OMB's own 60-day norm under Executive Order 12866 and shorter than every prior revision of this framework. The comment asks OMB to extend the period to no less than 90 days. Provision-specific objections include: § 200.205 (merit review): Inserting political appointee pre-issuance review above NIH peer review conflicts with 42 U.S.C. § 289a-1, under which the absence of a favorable peer-review recommendation is an absolute bar to funding. A regulation cannot make advisory what Congress made binding. Combined with the elimination of paylines, the provision creates an override mechanism structured to escape reasoned explanation and review. § 200.340 (termination and suspension): The discretionary termination standard, terminate whenever in the agency's interest, including priorities or the national interest "as they exist at the time of the termination," is an open-ended, retroactive condition that fails the Spending Clause requirements of Pennhurst and Dole. OMB's preamble characterizes the provision as a mere administrative feature to avoid Spending Clause scrutiny, a characterization the rest of the rulemaking contradicts. The parallel 90-day suspension authority replicates these defects while generating no reviewable record. § 200.220 (foreign collaboration): The provision extends the Wolf Amendment, a targeted single-agency appropriations rider, to every agency and every grant while removing the congressional and FBI oversight mechanisms Congress built in. Its indirect-cost prohibition is unworkable as applied to the most common forms of international collaboration. Additional provisions addressed include § 200.219 (viewpoint-neutral events), § 200.206 (applicant risk screening), § 200.450 (issue advocacy), § 200.432 (conference costs, with recommended alternatives), § 200.461 (publication costs, which conflict with federal public-access mandates), and § 200.339 (agency cooperation in private litigation). The comment concludes that the rule's core provisions are not financial-management policy but a structural reorganization of the relationship between the federal government and the scientific enterprise, requiring congressional authorization that does not exist. It identifies congressional mechanisms (the Congressional Review Act, appropriations language, and authorization legislation) available to address the rulemaking.